Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma

Erlotinib is an oral tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR) pathway. Although our previous study has proved the efficacy of Erlotinib in head and neck squamous cell carcinoma (HNSCC), it has also demonstrated poor clinical response rates and disappointing results in cli...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cell Commun Signal
Päätekijät: Zheng, Yang, Song, An, Zhou, Yan, Zhong, Yi, Zhang, Wei, Wang, Chundi, Ding, Xu, Du, Yifei, Li, Gang, Wu, Heming, Wu, Yunong, Song, Xiaomeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Netherlands 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7642164/
https://ncbi.nlm.nih.gov/pubmed/32157550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-020-00546-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia